Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara

Verified siteinfo

Romania Strada Doctor Iosif Nemoianu 2, 300011 Timisoara, Romania

12 trials recruiting
Schizophrenia · Hyperkalaemia · Juvenile absence epilepsy
Adults and children

About Specializations

Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara in Timisoara, Romania specialises in clinical trials of conditions such as Schizophrenia, Hyperkalaemia, Juvenile absence epilepsy, Petit mal epilepsy, and other specialisations. This site conducts important research.

Main research areas of the site

Pediatric Nephrology

The medical center is at the forefront of pediatric nephrology, focusing on innovative treatments for children with kidney-related conditions. The ongoing research aims to address complex issues such as anemia associated with chronic kidney disease (CKD) in young patients.

Chronic Kidney Disease in Children
Anemia Management in Pediatric Patients
Pharmacokinetics and Pharmacodynamics in Pediatrics

By exploring the efficacy of novel therapies like roxadustat, the center contributes significantly to improving the quality of life for children suffering from CKD-related anemia.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Strada Doctor Iosif Nemoianu 2300011 TimisoaraRomania

Open in maps ↗

Recruiting now: 12 trials
Conditions studied: 15
Partner status: Verified site

More sites in Timisoara Romania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

18 clinical trials

Schizophrenia+1

Recruiting

Long‑Term Safety and Tolerability of KarXT in Adolescents with Schizophrenia and of KarXT + KarX‑EC in Children and Adolescents with Autism‑Related Irritability

InvestigationalNo placebo

Long‑Term Safety and Tolerability of KarXT in Adolescents with Schizophrenia and of KarXT + KarX‑EC in Children and Adolescents with Autism‑Related Irritability

InvestigationalNo placebo

Romania

Participants:0–17 years
Substances:Trospium Chloride
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Schizophrenia

Recruiting

A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

Investigational

A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

Investigational

Romania

Participants:0–17 years
Substances:Trospium Chloride
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Hyperkalaemia

Recruiting

A study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia

InvestigationalNo placebo

A study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia

InvestigationalNo placebo

Romania

Participants:0–17 years
Substances:Patiromer
Sponsor:Vifor Pharma Inc.

Contact Research Centre

Haemophilia

Recruiting

A study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors

InvestigationalNo placebo

A study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors

InvestigationalNo placebo

Romania

Participants:0–17 years
Substances:Fitusiran
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Major depression

Recruiting

A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

Registered drug